Results
|
1061.
|
|
|
1062.
|
|
|
1063.
|
A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients. [electronic resource] by
- Vo, Ashley A
- Zeevi, Adriana
- Choi, Jua
- Cisneros, Kristen
- Toyoda, Mieko
- Kahwaji, Joseph
- Peng, Alice
- Villicana, Rafael
- Puliyanda, Dechu
- Reinsmoen, Nancy
- Haas, Mark
- Jordan, Stanley C
Producer: 20150615
In:
Transplantation vol. 99
Availability: No items available.
|
|
1064.
|
|
|
1065.
|
|
|
1066.
|
|
|
1067.
|
C1-esterase-inhibitor for primary graft dysfunction in lung transplantation. [electronic resource] by
- Sommer, Wiebke
- Tudorache, Igor
- Kühn, Christian
- Avsar, Murat
- Salman, Jawad
- Ius, Fabio
- Gras, Clemens
- Weber, Petra
- Welte, Tobias
- Gottlieb, Jens
- Haverich, Axel
- Warnecke, Gregor
Producer: 20140721
In:
Transplantation vol. 97
Availability: No items available.
|
|
1068.
|
|
|
1069.
|
|
|
1070.
|
|
|
1071.
|
|
|
1072.
|
|
|
1073.
|
|
|
1074.
|
|
|
1075.
|
|
|
1076.
|
Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition. [electronic resource] by
- Schwertz, Hansjörg
- Carter, Justin M
- Russ, Martin
- Schubert, Sebastian
- Schlitt, Axel
- Buerke, Ute
- Schmidt, Martin
- Hillen, Heinz
- Werdan, Karl
- Buerke, Michael
Producer: 20081118
In:
Journal of cardiovascular pharmacology vol. 52
Availability: No items available.
|
|
1077.
|
|
|
1078.
|
|
|
1079.
|
Complement is activated in progressive multiple sclerosis cortical grey matter lesions. [electronic resource] by
- Watkins, Lewis M
- Neal, James W
- Loveless, Sam
- Michailidou, Iliana
- Ramaglia, Valeria
- Rees, Mark I
- Reynolds, Richard
- Robertson, Neil P
- Morgan, B Paul
- Howell, Owain W
Producer: 20171010
In:
Journal of neuroinflammation vol. 13
Availability: No items available.
|
|
1080.
|
|